bioAffinity Technologies, Inc. (BIAFW) Stock Overview
Explore bioAffinity Technologies, Inc.’s financial performance, market position, analyst ratings, and future outlook.
bioAffinity Technologies, Inc. (BIAFW)
Key Financials
Key Financials
Market Cap
2.5M
P/E Ratio
-0.05
EPS (TTM)
$0.26
ROE
-2.57%
BIAFW Stock Analysis & Investment Overview (NASDAQ)
Our AI-powered analysis of bioAffinity Technologies, Inc. (NASDAQ: BIAFW) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of C+, bioAffinity Technologies, Inc.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.
The current technical analysis of BIAFW on the NASDAQ shows an RSI of 44.45, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $0.12 for the NASDAQ listing.
Key metrics behind bioAffinity Technologies, Inc.'s NASDAQ-traded stock include a P/E ratio of -0.05 and a market capitalization of 2.5M. Combined with our AI analysis, these give both institutional and retail investors a clear view of BIAFW on the NASDAQ.